Li Zhu

Biochemistry, Genetics and Molecular BiologyNeuroscienceEngineeringMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908”.

Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908

Neuro-Oncology(2023)10.1093/neuonc/noad031

N/A

1.3DataRank · unranked

65 citations

François Doz, Nicholas K. Foreman, Darren Hargrave, Álvaro Lassaletta, Nicolás André +14 more